Flutter helps 'The Tour 21' fundraise £1m for Cure Leukaemia
Flutter Entertainment is delighted to announced that it has helped national blood cancer charity Cure Leukaemia, reach its £1million fundraising target for its flagship cycling event - 'The Tour 21'. Flutter is the headline partner for the 2023, 2024 and 2025 iterations of the event.
A team of 18 amateur cyclists has spent the past three weeks cycling across Spain and France as part of 'The Tour 21', in partnership with Flutter, on behalf of Cure Leukaemia – a feat which has seen them complete all stages of the Tour de France – one week ahead of the professionals. Made up of cyclists from across the world, the team completed all 3,400km of the world’s most famous and prestigious professional cycling event.
The team this year were pushed to their physical limits in what has been the most mountainous Tour route since its inception. Moreover, two Flutter colleagues joined the team for two stages of the event including this year’s Queen Stage.
Five mountain ranges were tackled in total – the Pyrenees, Massif Central, Jura, Alps and Vosges. Over the course of the 21 stages, the team, representing four different countries, cycled over 55,000m of elevation – the equivalent of climbing Mount Everest over six times – or 183 Eiffel Towers.
All funds raised by 'The Tour 21' team will be invested in Cure Leukaemia’s Trials Acceleration Programme (TAP). The TAP Network is a network of specialist Research Nurses at 15 blood cancer centres. This network enables accelerated setup and delivery of potentially life-saving blood cancer clinical trials giving patients access to treatments not currently available through standard care.
Kerry McNally, Group Head of Communities, said: “We are thrilled to have reached the £1million donation mark in support of The Tour 21 Riders as the challenge comes to a close.
“Through Cure Leukaemia’s Trials Acceleration Programme (TAP), the money raised by 'The Tour 21' will support a new clinical trial for patients living with Acute Lymphoblastic Leukaemia (ALL). As headline sponsors, we are immensely proud to be a part of the effort to eradicate this disease.
“This partnership brings together our passion for sport with our commitment to Do More, helping support the communities in which we operate, and with the aim of helping 10 million people by the end of 2030. The money raised across the event will help us to achieve this goal and we’re excited to continue working with the Cure Leukaemia team.
As part of our Positive Impact Plan, we combine the power of sport and play, the passion of our people and the reach of our brands to ‘Do More’ for our communities around the world."
Professor Charlie Craddock CBE, Cure Leukaemia's Co-Founder, said: “The team may not be aware, but their bravery, their commitment to people who urgently need our help for new treatments and their vision that we can make the future better has galvanised the blood cancer community.
“The team have inspired blood cancer patients who are profoundly moved by the bravery that they have shown. And also, of course, critically, they have raised vital money to support Cure Leukaemia."
For further information, please contact email@example.com.
Sign up to email alerts here.